Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers
NCT02264067 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2014-10-15
Summary
To assess the pharmacokinetics and safety of WAL2014 capsules administered orally as a single dose to healthy adult male volunteers in double blind manner.
Conditions
- Healthy
Interventions
- DRUG
-
Talsaclidine
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 30 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1998-07-31
- Primary Completion
- 1998-11-30
More Related Trials
-
Mass Balance Study of [14C] TAS-205 in Healthy Volunteers
NCT04825431 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Absolute Bioavailability (ABA) of TAK-906 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]-TAK-906 in Healthy Male Participants
NCT04454918 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Absorption, Metabolism and Excretion Following a Single Oral Dose of [14C]KWA-0711 to Healthy Male Subjects
NCT02434835 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetic Characteristics and Safety of IN-C004 in Healthy Volunteers
NCT04654078 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of TAK-227 in Healthy Adults
NCT05818956 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic-pharmacodynamic Assessment of Seresis® in Healthy Volunteers
NCT02191787 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of Single and Multiple Ascending Doses of JNJ-41443532 in Healthy Male Participants
NCT01106469 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants
NCT04155567 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance Study of [14C]-NT-814 Oral Suspension in Healthy Male Subjects
NCT04654897 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male Participants
NCT05847439 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers
NCT03565861 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects
NCT03198624 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male
NCT07166887 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of Carbon-14 (14C)E7386 in Healthy Male Participants
NCT05607537 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label, Single-Dose Study of 14C-NW-3509 in Healthy Male Subjects
NCT03446274 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase 1 Clinical Trial of NTQ5082 in Healthy Volunteers
NCT06560593 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects
NCT05868967 ·Status: UNKNOWN ·Phase: PHASE1
-
Open, Single-dose/-Period Study to Assess Mass Balance Recovery, Metabolite Profile/Identification of 14C-Varlitinib
NCT03368846 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4
NCT01056575 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers
NCT02259842 ·Status: COMPLETED ·Phase: PHASE1
-
A Water Consumption Study of ALKS 5461 in Healthy Volunteers
NCT02521857 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Plasma Levels of N-Methanocarbathymidine (N-MCT) in Normal Patients
NCT02778386 ·Status: UNKNOWN ·Phase: PHASE1
-
Absorption, Metabolism, and Excretion Study of [14C]-TNP-2092
NCT05074134 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Pharmacokinetics of Intravenous Administered 14C-MNTX
NCT01367483 ·Status: COMPLETED ·Phase: PHASE1
-
TD-1211 IV/Oral Mass Balance Study
NCT01702194 ·Status: COMPLETED ·Phase: PHASE1